Group 1 - The core point of the article highlights that Conade Biotech (CNTB.OQ) experienced a stock price decline on February 12, 2026, closing at $2.47, which represents a drop of 7.84% [1] - On the same day, the overall biotechnology sector in the U.S. saw a slight increase of 0.24%, while the Nasdaq index fell by 2.03%, indicating that the pressure on tech growth stocks may have influenced individual stock sentiment [1] Group 2 - The stock has shown significant volatility recently, with a price fluctuation of 23.61% from February 5 to February 11, including a notable single-day increase of 11.93% on February 9, followed by two days of decline [2] - The decline on February 12 may include some technical correction factors, and the low turnover rate of 0.20% suggests limited liquidity, which could amplify price volatility [2]
康乃德生物股价下跌7.84%，美股科技板块承压
Jing Ji Guan Cha Wang·2026-02-13 13:12